Sengenics profiles autoantibody responses using functional protein arrays built with correctly folded proteins. Its KREX-based technology is designed to preserve conformational epitopes, enabling researchers to detect immune recognition patterns that may be lost on arrays made with denatured proteins. The platform supports biomarker discovery, patient stratification, treatment-response research, and safety studies in autoimmune disease, oncology, neurology, and other immune-involved conditions.
Sengenics
Sengenics is a functional proteomics company utilizing its proprietary KREX™ protein array technology to discover autoantibody biomarkers for precision medicine. Supporting oncology, autoimmune, and neurology therapeutic pipelines, Sengenics provides unique insights into the immune system's response to disease, facilitating patient stratification and drug safety evaluation.
